Resonant Capital Advisors, LLC Pfizer Inc Transaction History

Resonant Capital Advisors, LLC

$1.34 Billion
Q3 2024

A detailed history of Resonant Capital Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Resonant Capital Advisors, LLC holds 108,033 shares of PFE stock, worth $2.89 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

108,033

Previous 106,369 1.56%

Holding current value

$2.89 Million

Previous $2.98 Million 5.04%

% of portfolio

0.23%

Previous 0.24%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$27.7 - $31.39 $46,092 - $52,232	1,664 Added 1.56%	108,033 $3.13 Million
Q2 2024 Aug 01, 2024	BUY	$25.26 - $29.6 $113,796 - $133,348	4,505 Added 4.42%	106,369 $2.98 Million
Q1 2024 May 01, 2024	BUY	$25.89 - $29.73 $102,679 - $117,909	3,966 Added 4.05%	101,864 $2.83 Million
Q4 2023 Jan 31, 2024	BUY	$26.13 - $33.94 $255,081 - $331,322	9,762 Added 11.08%	97,898 $2.82 Million
Q3 2023 Oct 31, 2023	BUY	$32.09 - $37.51 $41,171 - $48,125	1,283 Added 1.48%	88,136 $2.92 Million
Q2 2023 Jul 25, 2023	BUY	$36.12 - $41.79 $24,128 - $27,915	668 Added 0.78%	86,853 $3.19 Million
Q1 2023 Apr 21, 2023	BUY	$39.39 - $51.28 $2,205 - $2,871	56 Added 0.07%	86,185 $3.52 Million
Q4 2022 Jan 23, 2023	BUY	$41.75 - $54.5 $147,043 - $191,949	3,522 Added 4.26%	86,129 $0
Q3 2022 Oct 20, 2022	SELL	$43.76 - $53.42 $83,362 - $101,765	-1,905 Reduced 2.25%	82,607 $3.62 Million
Q2 2022 Jul 12, 2022	BUY	$46.53 - $55.17 $35,502 - $42,094	763 Added 0.91%	84,512 $4.43 Million
Q1 2022 Apr 19, 2022	BUY	$45.75 - $56.69 $184,098 - $228,120	4,024 Added 5.05%	83,749 $4.32 Million
Q4 2021 Jan 26, 2022	BUY	$41.32 - $61.25 $258,911 - $383,792	6,266 Added 8.53%	79,725 $4.71 Million
Q3 2021 Oct 18, 2021	BUY	$39.25 - $50.42 $291,470 - $374,418	7,426 Added 11.25%	73,459 $3.16 Million
Q2 2021 Jul 16, 2021	BUY	$35.91 - $40.68 $5,422 - $6,142	151 Added 0.23%	66,033 $2.59 Million
Q1 2021 Apr 28, 2021	BUY	$33.49 - $37.77 $156,934 - $176,990	4,686 Added 7.66%	65,882 $2.39 Million
Q4 2020 Jan 15, 2021	BUY	$33.47 - $42.56 $74,202 - $94,355	2,217 Added 3.76%	61,196 $2.25 Million
Q3 2020 Nov 03, 2020	BUY	$31.75 - $37.25 $23,939 - $28,086	754 Added 1.29%	58,979 $2.17 Million
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $352,404 - $427,518	-11,700 Reduced 16.73%	58,225 $1.9 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $90,253 - $128,952	3,339 Added 5.01%	69,925 $2.28 Million
Q4 2019 Feb 18, 2020	BUY	$32.92 - $37.36 $2.19 Million - $2.49 Million	66,586 New	66,586 $2.61 Million

Others Institutions Holding PFE

# of Institutions

3,271

Shares Held

3.63B

Call Options Held

74.3M

Put Options Held

107M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Resonant Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resonant Capital Advisors, LLC with notifications on news.

Account

Resonant Capital Advisors, LLC Pfizer Inc Transaction History